United States Biotechnology & Medical Research

Cue Biopharma Inc (CUE)

Cue Biopharma Inc. experienced significant insider selling over the past ninety days, totaling approximately 2.43 million dollars in net value. Executives, including the CEO, offloaded shares following a challenging earnings report. These transactions occurred amidst a 39.7 percent decline in stock price, reflecting notable divestment activity by key leadership personnel.
Ticker: CUE Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Cue Biopharma Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Meluzio Michael Vincent VP, Prin. Accounting Officer Officer
Transaction date
Sale
Price
202.61
Quantity 48,585 -40.6%
Value US$989,825
Ray Sumita Chief Legal Compliance Officer Officer
Transaction date
Sale
Price
141.95
Quantity 63,276 -48.7%
Value US$4,270,580
3.1
Lin Shao-Lee Chief Executive Officer Executive Director
Transaction date
Sale
Price
324.47
Quantity 23,294 +15.9%
Value US$3,482,772
3.1
Lin Shao-Lee Chief Executive Officer Executive Director
Transaction date
Sale
Price
27.50
Quantity 10,000 -1.4%
Value US$275,000
3.1
Shao-Lee Lin Officer; Director Executive Director
Transaction date
Proposed sale
Price
27.55
Quantity 11,087
Value US$305,490
Sumita Ray Officer; CORPORATE SECRETARY Officer
Transaction date
Proposed sale
Price
28.05
Quantity 1,844
Value US$51,724
Ray Sumita Chief Legal Compliance Officer Officer
Transaction date
Sale
Price
31.13
Quantity 4 -0.0%
Value US$125
Ray Sumita Chief Legal Compliance Officer Officer
Transaction date
Sale
Price
30.35
Quantity 6,442 -5.2%
Value US$195,515
Ray Sumita Chief Legal Compliance Officer Officer
Transaction date
Sale
Price
29.37
Quantity 2,383 -1.9%
Value US$69,989
Meluzio Michael Vincent VP, Prin. Accounting Officer Officer
Transaction date
Sale
Price
31.13
Quantity 3 -0.0%
Value US$93
Meluzio Michael Vincent VP, Prin. Accounting Officer Officer
Transaction date
Sale
Price
30.35
Quantity 4,106 -7.7%
Value US$124,617
Meluzio Michael Vincent VP, Prin. Accounting Officer Officer
Transaction date
Sale
Price
29.37
Quantity 1,519 -2.8%
Value US$44,613
3.1
Lin Shao-Lee Chief Executive Officer Executive Director
Transaction date
Sale
Price
29.48
Quantity 10,460 -1.5%
Value US$308,361
3.1
Lin Shao-Lee Chief Executive Officer Executive Director
Transaction date
Sale
Price
28.11
Quantity 2,375 -0.3%
Value US$66,761
3.1
Lin Shao-Lee Chief Executive Officer Executive Director
Transaction date
Sale
Price
27.19
Quantity 5,423 -0.7%
Value US$147,451
3.1
Shao-Lee Lin Officer; Director Executive Director
Transaction date
Proposed sale
Price
28.26
Quantity 18,258
Value US$515,971
Sumita Ray Officer; CORPORATE SECRETARY Officer
Transaction date
Proposed sale
Price
30.14
Quantity 8,829
Value US$266,106
3.1
Lin Shao-Lee Chief Executive Officer Executive Director
Transaction date
Sale
Price
27.75
Quantity 5,775 -0.8%
Value US$160,256
3.1
Lin Shao-Lee Chief Executive Officer Executive Director
Transaction date
Sale
Price
26.99
Quantity 34,225 -4.5%
Value US$923,733
3.1
Shao-Lee Lin Officer; Director Executive Director
Transaction date
Proposed sale
Price
27.01
Quantity 40,000
Value US$1,080,400
2.4
Sarraf Pasha Non-Executive Director
Transaction date
Purchase
Price
0.30
Quantity 77,417 +31.4%
Value US$23,349
2.4
Sarraf Pasha Non-Executive Director
Transaction date
Purchase
Price
0.31
Quantity 78,116 +46.4%
Value US$24,325
2.4
Sarraf Pasha Non-Executive Director
Transaction date
Purchase
Price
0.32
Quantity 86,947 +106.8%
Value US$27,597
2.4
Sarraf Pasha Non-Executive Director
Transaction date
Purchase
Price
0.30
Quantity 77,148 +1824.3%
Value US$23,168
2.4
Sarraf Pasha Non-Executive Director
Transaction date
Purchase
Price
0.31
Quantity 4,229 New position
Value US$1,308
MATTEO GIACOMO LEVISETTI Officer Officer
Transaction date
Proposed sale
Price
0.26
Quantity 7,230
Value US$1,907
2.5
PASSERI DANIEL R CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
1.03
Quantity 30,000 +22.3%
Value US$30,900
1.4
Suri Anish PRESIDENT AND CSO Officer
Transaction date
Purchase
Price
2.76
Quantity 4,000 +3.0%
Value US$11,040
2.5
PASSERI DANIEL R CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
2.86
Quantity 3,000 +2.3%
Value US$8,580
0.6
Kiener Peter A Non-Executive Director
Transaction date
Sale
Price
3.28
Quantity 9,325 -96.3%
Value US$30,586
0.6
Morich Frank Non-Executive Director
Transaction date
Purchase
Price
3.75
Quantity 28,000 New position
Value US$105,000
2.7
Fletcher Aaron G.L. Non-Executive Director
Transaction date
Purchase
Price
3.34
Quantity 55,000 +6.2%
Value US$183,700
2.7
Fletcher Aaron G.L. Non-Executive Director
Transaction date
Purchase
Price
3.52
Quantity 150,000 +20.4%
Value US$528,000
2.7
Fletcher Aaron G.L. Non-Executive Director
Transaction date
Purchase
Price
4.76
Quantity 735,000 New position
Value US$3,498,600
0.6
Kiener Peter A Non-Executive Director
Transaction date
Planned sale
Price
18.02
Quantity 1,361 -100.0%
Value US$24,525
0.6
Kiener Peter A Non-Executive Director
Transaction date
Planned sale
Price
17.92
Quantity 18,815 -100.0%
Value US$337,165
1.4
Suri Anish President and CSO Officer
Transaction date
Planned sale
Price
18.05
Quantity 8,000 -7.8%
Value US$144,400
1.4
Suri Anish President and CSO Officer
Transaction date
Planned sale
Price
15.07
Quantity 20,000 -17.5%
Value US$301,354
Millar Kerri-Ann CHIEF FINANCIAL OFFICER Officer
Transaction date
Planned sale
Price
14.21
Quantity 1,251 -10.7%
Value US$17,783
2.5
PASSERI DANIEL R CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
14.72
Quantity 3,400 +6.5%
Value US$50,051
1.4
Suri Anish PRESIDENT AND CSO Officer
Transaction date
Planned sale
Price
15.23
Quantity 20,000 -21.1%
Value US$304,646
0.8
Pienta Kenneth Chief Medical Officer Officer
Transaction date
Planned sale
Price
15.09
Quantity 439 -18.0%
Value US$6,626
0.8
Pienta Kenneth Chief Medical Officer Officer
Transaction date
Planned sale
Price
15.10
Quantity 13,000 -86.7%
Value US$196,269
0.8
Pienta Kenneth Chief Medical Officer Officer
Transaction date
Planned sale
Price
15.06
Quantity 4,274 -68.1%
Value US$64,345
0.8
Pienta Kenneth Chief Medical Officer Officer
Transaction date
Planned sale
Price
15.15
Quantity 16,000 -88.9%
Value US$242,422
0.8
Pienta Kenneth Chief Medical Officer Officer
Transaction date
Purchase
Price
15.07
Quantity 2,720 +136.0%
Value US$40,980
2.7
Fletcher Aaron G.L. Non-Executive Director
Transaction date
Purchase
Price
12.64
Quantity 6,548 +4.1%
Value US$82,776
1.0
Gray Cameron Non-Executive Director
Transaction date
Purchase
Price
15.30
Quantity 5,000 +0.7%
Value US$76,500
1.0
Gray Cameron Non-Executive Director
Transaction date
Purchase
Price
15.00
Quantity 5,000 +0.7%
Value US$75,000
2.0
Sandercock Colin SVP, General Counsel and Sec Officer
Transaction date
Planned sale
Price
20.00
Quantity 13,274 -43.7%
Value US$265,480
1.4
Suri Anish President and CSO Officer
Transaction date
Planned sale
Price
20.01
Quantity 800 -2.3%
Value US$16,008
1.4
Suri Anish President and CSO Officer
Transaction date
Planned sale
Price
20.14
Quantity 400 -1.1%
Value US$8,056
2.0
Sandercock Colin SVP, General Counsel and Sec Officer
Transaction date
Planned sale
Price
20.05
Quantity 201 -1.2%
Value US$4,030
1.4
Suri Anish President and CSO Officer
Transaction date
Planned sale
Price
20.01
Quantity 5,800 -14.4%
Value US$116,058
2.0
Sandercock Colin SVP, General Counsel and Sec Officer
Transaction date
Planned sale
Price
20.00
Quantity 6,425 -27.3%
Value US$128,500
2.7
Fletcher Aaron G.L. Non-Executive Director
Transaction date
Purchase
Price
25.24
Quantity 2,953 +1.9%
Value US$74,534
2.7
Fletcher Aaron G.L. Non-Executive Director
Transaction date
Purchase
Price
24.64
Quantity 4,547 +3.0%
Value US$112,038
MARLETT CHRISTOPHER A Non-Executive Director
Transaction date
Sale
Price
15.71
Quantity 9,000 -100.0%
Value US$141,390
MARLETT CHRISTOPHER A Non-Executive Director
Transaction date
Sale
Price
15.77
Quantity 6,700 -0.9%
Value US$105,659
MARLETT CHRISTOPHER A Non-Executive Director
Transaction date
Sale
Price
17.24
Quantity 9,000 -1.1%
Value US$155,160
MARLETT CHRISTOPHER A Non-Executive Director
Transaction date
Sale
Price
17.53
Quantity 19,647 -2.4%
Value US$344,412
MARLETT CHRISTOPHER A Non-Executive Director
Transaction date
Sale
Price
16.82
Quantity 17,000 -2.1%
Value US$285,940
MARLETT CHRISTOPHER A Non-Executive Director
Transaction date
Sale
Price
17.00
Quantity 4,000 -0.5%
Value US$68,000
MARLETT CHRISTOPHER A Non-Executive Director
Transaction date
Sale
Price
15.73
Quantity 20,732 -2.5%
Value US$326,114
2.5
PASSERI DANIEL R CEO and President Executive Director
Transaction date
Purchase
Price
7.26
Quantity 1,377 +2.7%
Value US$9,997
2.0
Sandercock Colin SVP, General Counsel and Sec
Transaction date
Purchase
Price
7.93
Quantity 14,938 +746.9%
Value US$118,458
2.0
Sandercock Colin SVP, General Counsel and Sec
Transaction date
Purchase
Price
7.10
Quantity 2,000 New position
Value US$14,200
2.5
PASSERI DANIEL R CEO and President Executive Director
Transaction date
Purchase
Price
6.90
Quantity 3,000 +6.3%
Value US$20,700
3.8
MARLETT CHRISTOPHER A Non-Executive Director
Transaction date
Purchase
Price
4.64
Quantity 18,521 +26.1%
Value US$85,937
3.4
DIGIANDOMENICO ANTHONY Non-Executive Director
Transaction date
Purchase
Price
4.62
Quantity 7,000 +14.0%
Value US$32,340
DIGIANDOMENICO ANTHONY Non-Executive Director
Transaction date
Purchase
Price
4.77
Quantity 20,000 +66.7%
Value US$95,400
MARLETT CHRISTOPHER A Non-Executive Director
Transaction date
Purchase
Price
4.29
Quantity 19,647 +38.2%
Value US$84,286
3.4
DIGIANDOMENICO ANTHONY Non-Executive Director
Transaction date
Purchase
Price
4.81
Quantity 10,000 +50.0%
Value US$48,100
Suri Anish Chief Scientific Officer Officer
Transaction date
Purchase
Price
4.37
Quantity 2,000 New position
Value US$8,740
MARLETT CHRISTOPHER A Non-Executive Director
Transaction date
Purchase
Price
4.53
Quantity 17,200 +50.2%
Value US$77,916
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-10-14 2026-10-12 S Sale
Meluzio Michael Vincent

VP, Prin. Accounting Officer

Officer
48,585 -40.6%
202.61
US$989,825 		48,585 -40.6% 202.61 US$989,825
2026-10-14 2026-10-12 S Sale
Ray Sumita

Chief Legal Compliance Officer

Officer
63,276 -48.7%
141.95
US$4,270,580 		63,276 -48.7% 141.95 US$4,270,580
2026-10-14 2026-10-12 S Sale
3.1
Lin Shao-Lee

Chief Executive Officer

Executive Director
23,294 +15.9%
324.47
US$3,482,772 		23,294 +15.9% 324.47 US$3,482,772
2026-10-14 2026-10-12 S Sale
3.1
Lin Shao-Lee

Chief Executive Officer

Executive Director
10,000 -1.4%
27.50
US$275,000 		10,000 -1.4% 27.50 US$275,000
2026-10-13 2026-10-12 PrS Proposed sale
3.1
Shao-Lee Lin

Officer; Director

Executive Director
11,087
27.55
US$305,490 		11,087 27.55 US$305,490
2026-10-13 2026-10-12 PrS Proposed sale
Sumita Ray

Officer; CORPORATE SECRETARY

Officer
1,844
28.05
US$51,724 		1,844 28.05 US$51,724
2026-08-17 2026-08-13 S Sale
Ray Sumita

Chief Legal Compliance Officer

Officer
4 -0.0%
31.13
US$125 		4 -0.0% 31.13 US$125
2026-08-17 2026-08-13 S Sale
Ray Sumita

Chief Legal Compliance Officer

Officer
6,442 -5.2%
30.35
US$195,515 		6,442 -5.2% 30.35 US$195,515
2026-08-17 2026-08-13 S Sale
Ray Sumita

Chief Legal Compliance Officer

Officer
2,383 -1.9%
29.37
US$69,989 		2,383 -1.9% 29.37 US$69,989
2026-08-17 2026-08-13 S Sale
Meluzio Michael Vincent

VP, Prin. Accounting Officer

Officer
3 -0.0%
31.13
US$93 		3 -0.0% 31.13 US$93
2026-08-17 2026-08-13 S Sale
Meluzio Michael Vincent

VP, Prin. Accounting Officer

Officer
4,106 -7.7%
30.35
US$124,617 		4,106 -7.7% 30.35 US$124,617
2026-08-17 2026-08-13 S Sale
Meluzio Michael Vincent

VP, Prin. Accounting Officer

Officer
1,519 -2.8%
29.37
US$44,613 		1,519 -2.8% 29.37 US$44,613
2026-08-14 2026-08-13 S Sale
3.1
Lin Shao-Lee

Chief Executive Officer

Executive Director
10,460 -1.5%
29.48
US$308,361 		10,460 -1.5% 29.48 US$308,361
2026-08-14 2026-08-13 S Sale
3.1
Lin Shao-Lee

Chief Executive Officer

Executive Director
2,375 -0.3%
28.11
US$66,761 		2,375 -0.3% 28.11 US$66,761
2026-08-14 2026-08-13 S Sale
3.1
Lin Shao-Lee

Chief Executive Officer

Executive Director
5,423 -0.7%
27.19
US$147,451 		5,423 -0.7% 27.19 US$147,451
2026-08-14 2026-08-13 PrS Proposed sale
3.1
Shao-Lee Lin

Officer; Director

Executive Director
18,258
28.26
US$515,971 		18,258 28.26 US$515,971
2026-08-13 2026-08-13 PrS Proposed sale
Sumita Ray

Officer; CORPORATE SECRETARY

Officer
8,829
30.14
US$266,106 		8,829 30.14 US$266,106
2026-08-14 2026-08-12 S Sale
3.1
Lin Shao-Lee

Chief Executive Officer

Executive Director
5,775 -0.8%
27.75
US$160,256 		5,775 -0.8% 27.75 US$160,256
2026-08-14 2026-08-12 S Sale
3.1
Lin Shao-Lee

Chief Executive Officer

Executive Director
34,225 -4.5%
26.99
US$923,733 		34,225 -4.5% 26.99 US$923,733
2026-08-14 2026-08-12 PrS Proposed sale
3.1
Shao-Lee Lin

Officer; Director

Executive Director
40,000
27.01
US$1,080,400 		40,000 27.01 US$1,080,400
2026-01-02 2025-12-30 B Purchase
2.4
Sarraf Pasha
Non-Executive Director
77,417 +31.4%
0.30
US$23,349 		77,417 +31.4% 0.30 US$23,349
2026-01-02 2025-12-30 B Purchase
2.4
Sarraf Pasha
Non-Executive Director
78,116 +46.4%
0.31
US$24,325 		78,116 +46.4% 0.31 US$24,325
2026-01-02 2025-12-30 B Purchase
2.4
Sarraf Pasha
Non-Executive Director
86,947 +106.8%
0.32
US$27,597 		86,947 +106.8% 0.32 US$27,597
2026-01-02 2025-12-30 B Purchase
2.4
Sarraf Pasha
Non-Executive Director
77,148 +1824.3%
0.30
US$23,168 		77,148 +1824.3% 0.30 US$23,168
2026-01-02 2025-12-30 B Purchase
2.4
Sarraf Pasha
Non-Executive Director
4,229 New position
0.31
US$1,308 		4,229 New position 0.31 US$1,308
2025-12-29 2025-12-29 PrS Proposed sale
MATTEO GIACOMO LEVISETTI

Officer

Officer
7,230
0.26
US$1,907 		7,230 0.26 US$1,907
2024-12-18 2024-12-16 B Purchase
2.5
PASSERI DANIEL R

CHIEF EXECUTIVE OFFICER

Executive Director
30,000 +22.3%
1.03
US$30,900 		30,000 +22.3% 1.03 US$30,900
2023-08-29 2023-08-25 B Purchase
1.4
Suri Anish

PRESIDENT AND CSO

Officer
4,000 +3.0%
2.76
US$11,040 		4,000 +3.0% 2.76 US$11,040
2023-08-16 2023-08-14 B Purchase
2.5
PASSERI DANIEL R

CHIEF EXECUTIVE OFFICER

Executive Director
3,000 +2.3%
2.86
US$8,580 		3,000 +2.3% 2.86 US$8,580
2023-03-27 2023-03-23 S Sale
0.6
Kiener Peter A
Non-Executive Director
9,325 -96.3%
3.28
US$30,586 		9,325 -96.3% 3.28 US$30,586
2022-05-31 2022-05-27 B Purchase
0.6
Morich Frank
Non-Executive Director
28,000 New position
3.75
US$105,000 		28,000 New position 3.75 US$105,000
2022-05-25 2022-05-24 B Purchase
2.7
Fletcher Aaron G.L.
Non-Executive Director
55,000 +6.2%
3.34
US$183,700 		55,000 +6.2% 3.34 US$183,700
2022-05-25 2022-05-23 B Purchase
2.7
Fletcher Aaron G.L.
Non-Executive Director
150,000 +20.4%
3.52
US$528,000 		150,000 +20.4% 3.52 US$528,000
2022-04-04 2022-03-31 B Purchase
2.7
Fletcher Aaron G.L.
Non-Executive Director
735,000 New position
4.76
US$3,498,600 		735,000 New position 4.76 US$3,498,600
2021-11-17 2021-11-16 PlS Planned sale
0.6
Kiener Peter A
Non-Executive Director
1,361 -100.0%
18.02
US$24,525 		1,361 -100.0% 18.02 US$24,525
2021-11-17 2021-11-15 PlS Planned sale
0.6
Kiener Peter A
Non-Executive Director
18,815 -100.0%
17.92
US$337,165 		18,815 -100.0% 17.92 US$337,165
2021-11-17 2021-11-15 PlS Planned sale
1.4
Suri Anish

President and CSO

Officer
8,000 -7.8%
18.05
US$144,400 		8,000 -7.8% 18.05 US$144,400
2021-11-15 2021-11-11 PlS Planned sale
1.4
Suri Anish

President and CSO

Officer
20,000 -17.5%
15.07
US$301,354 		20,000 -17.5% 15.07 US$301,354
2021-10-05 2021-10-01 PlS Planned sale
Millar Kerri-Ann

CHIEF FINANCIAL OFFICER

Officer
1,251 -10.7%
14.21
US$17,783 		1,251 -10.7% 14.21 US$17,783
2021-09-27 2021-09-24 B Purchase
2.5
PASSERI DANIEL R

CHIEF EXECUTIVE OFFICER

Executive Director
3,400 +6.5%
14.72
US$50,051 		3,400 +6.5% 14.72 US$50,051
2021-09-27 2021-09-23 PlS Planned sale
1.4
Suri Anish

PRESIDENT AND CSO

Officer
20,000 -21.1%
15.23
US$304,646 		20,000 -21.1% 15.23 US$304,646
2021-03-17 2021-03-16 PlS Planned sale
0.8
Pienta Kenneth

Chief Medical Officer

Officer
439 -18.0%
15.09
US$6,626 		439 -18.0% 15.09 US$6,626
2021-03-17 2021-03-15 PlS Planned sale
0.8
Pienta Kenneth

Chief Medical Officer

Officer
13,000 -86.7%
15.10
US$196,269 		13,000 -86.7% 15.10 US$196,269
2021-02-18 2021-02-17 PlS Planned sale
0.8
Pienta Kenneth

Chief Medical Officer

Officer
4,274 -68.1%
15.06
US$64,345 		4,274 -68.1% 15.06 US$64,345
2021-02-18 2021-02-16 PlS Planned sale
0.8
Pienta Kenneth

Chief Medical Officer

Officer
16,000 -88.9%
15.15
US$242,422 		16,000 -88.9% 15.15 US$242,422
2021-01-22 2021-01-20 B Purchase
0.8
Pienta Kenneth

Chief Medical Officer

Officer
2,720 +136.0%
15.07
US$40,980 		2,720 +136.0% 15.07 US$40,980
2020-11-25 2020-11-24 B Purchase
2.7
Fletcher Aaron G.L.
Non-Executive Director
6,548 +4.1%
12.64
US$82,776 		6,548 +4.1% 12.64 US$82,776
2020-10-01 2020-09-30 B Purchase
1.0
Gray Cameron
Non-Executive Director
5,000 +0.7%
15.30
US$76,500 		5,000 +0.7% 15.30 US$76,500
2020-10-01 2020-09-29 B Purchase
1.0
Gray Cameron
Non-Executive Director
5,000 +0.7%
15.00
US$75,000 		5,000 +0.7% 15.00 US$75,000
2020-08-07 2020-08-05 PlS Planned sale
2.0
Sandercock Colin

SVP, General Counsel and Sec

Officer
13,274 -43.7%
20.00
US$265,480 		13,274 -43.7% 20.00 US$265,480
2020-08-07 2020-08-05 PlS Planned sale
1.4
Suri Anish

President and CSO

Officer
800 -2.3%
20.01
US$16,008 		800 -2.3% 20.01 US$16,008
2020-08-05 2020-08-04 PlS Planned sale
1.4
Suri Anish

President and CSO

Officer
400 -1.1%
20.14
US$8,056 		400 -1.1% 20.14 US$8,056
2020-08-05 2020-08-04 PlS Planned sale
2.0
Sandercock Colin

SVP, General Counsel and Sec

Officer
201 -1.2%
20.05
US$4,030 		201 -1.2% 20.05 US$4,030
2020-08-05 2020-08-03 PlS Planned sale
1.4
Suri Anish

President and CSO

Officer
5,800 -14.4%
20.01
US$116,058 		5,800 -14.4% 20.01 US$116,058
2020-08-05 2020-08-03 PlS Planned sale
2.0
Sandercock Colin

SVP, General Counsel and Sec

Officer
6,425 -27.3%
20.00
US$128,500 		6,425 -27.3% 20.00 US$128,500
2020-06-25 2020-06-24 B Purchase
2.7
Fletcher Aaron G.L.
Non-Executive Director
2,953 +1.9%
25.24
US$74,534 		2,953 +1.9% 25.24 US$74,534
2020-06-25 2020-06-24 B Purchase
2.7
Fletcher Aaron G.L.
Non-Executive Director
4,547 +3.0%
24.64
US$112,038 		4,547 +3.0% 24.64 US$112,038
2019-12-31 2019-12-31 S Sale MARLETT CHRISTOPHER A Non-Executive Director
9,000 -100.0%
15.71
US$141,390 		9,000 -100.0% 15.71 US$141,390
2019-12-31 2019-12-31 S Sale MARLETT CHRISTOPHER A Non-Executive Director
6,700 -0.9%
15.77
US$105,659 		6,700 -0.9% 15.77 US$105,659
2019-12-31 2019-12-27 S Sale MARLETT CHRISTOPHER A Non-Executive Director
9,000 -1.1%
17.24
US$155,160 		9,000 -1.1% 17.24 US$155,160
2019-12-27 2019-12-26 S Sale MARLETT CHRISTOPHER A Non-Executive Director
19,647 -2.4%
17.53
US$344,412 		19,647 -2.4% 17.53 US$344,412
2019-12-27 2019-12-23 S Sale MARLETT CHRISTOPHER A Non-Executive Director
17,000 -2.1%
16.82
US$285,940 		17,000 -2.1% 16.82 US$285,940
2019-12-19 2019-12-19 S Sale MARLETT CHRISTOPHER A Non-Executive Director
4,000 -0.5%
17.00
US$68,000 		4,000 -0.5% 17.00 US$68,000
2019-12-19 2019-12-17 S Sale MARLETT CHRISTOPHER A Non-Executive Director
20,732 -2.5%
15.73
US$326,114 		20,732 -2.5% 15.73 US$326,114
2019-06-25 2019-06-21 B Purchase
2.5
PASSERI DANIEL R

CEO and President

Executive Director
1,377 +2.7%
7.26
US$9,997 		1,377 +2.7% 7.26 US$9,997
2019-06-10 2019-06-10 B Purchase
2.0
Sandercock Colin

SVP, General Counsel and Sec
14,938 +746.9%
7.93
US$118,458 		14,938 +746.9% 7.93 US$118,458
2019-06-10 2019-06-06 B Purchase
2.0
Sandercock Colin

SVP, General Counsel and Sec
2,000 New position
7.10
US$14,200 		2,000 New position 7.10 US$14,200
2019-06-07 2019-06-06 B Purchase
2.5
PASSERI DANIEL R

CEO and President

Executive Director
3,000 +6.3%
6.90
US$20,700 		3,000 +6.3% 6.90 US$20,700
2019-01-02 2018-12-31 B Purchase
3.8
MARLETT CHRISTOPHER A
Non-Executive Director
18,521 +26.1%
4.64
US$85,937 		18,521 +26.1% 4.64 US$85,937
2019-01-02 2018-12-28 B Purchase
3.4
DIGIANDOMENICO ANTHONY
Non-Executive Director
7,000 +14.0%
4.62
US$32,340 		7,000 +14.0% 4.62 US$32,340
2018-12-28 2018-12-27 B Purchase DIGIANDOMENICO ANTHONY Non-Executive Director
20,000 +66.7%
4.77
US$95,400 		20,000 +66.7% 4.77 US$95,400
2018-12-27 2018-12-26 B Purchase MARLETT CHRISTOPHER A Non-Executive Director
19,647 +38.2%
4.29
US$84,286 		19,647 +38.2% 4.29 US$84,286
2019-01-04 2018-12-24 B Purchase
3.4
DIGIANDOMENICO ANTHONY
Non-Executive Director
10,000 +50.0%
4.81
US$48,100 		10,000 +50.0% 4.81 US$48,100
2018-12-26 2018-12-21 B Purchase Suri Anish

Chief Scientific Officer

Officer
2,000 New position
4.37
US$8,740 		2,000 New position 4.37 US$8,740
2018-12-26 2018-12-21 B Purchase MARLETT CHRISTOPHER A Non-Executive Director
17,200 +50.2%
4.53
US$77,916 		17,200 +50.2% 4.53 US$77,916

See older Cue Biopharma Inc insider trades

Plus unlocks the full transaction history.

See localized pricing at checkout
Unlock Cue Biopharma Inc history with Plus

Billed monthly · Cancel anytime

Explore more

More insider trading research around Cue Biopharma Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America